Wang et al. (2006) [70] and Jin et al. (2011) [71] revealed that Cav1 was reduced in patients with IPF and Cav1 gene transfer ameliorates the fibrotic process by modulating TGF-β1-mediated Smad signaling and suppressing ECM production. This evidence concerns the gene CAV1 and idiopathic pulmonary fibrosis.